Ken Chigbo
Independent Analyst
- The US FDA will be leveraging blockchain technology to further optimize capabilities within the drug sector.
- Blue-chip companies including the likes of; IBM, Walmart, KPMH, Merck and others will work with the FDA.
The United States Food and Drug Administration (FDA) has announced a partnership with four blue-chip companies to leverage blockchain technology in the drug supply chain according to tech media outlet ZDNet.
The FDA has reportedly teamed up with the likes of; IBM, Walmart, Big Four auditor KPMG, and the world's oldest pharma firm Merck. They are keen to construct a proof-of-concept (PoC) blockchain network, so that data can be shared and tracked on distribution of prescription drugs.
Further within the report it details, the initiative is connected with the United States Drug Supply Chain Security Act (DSCSA) and intends to assist the FDA, as the goal is for optimizing the supply chain of pharma products.
Note: All information on this page is subject to change. The use of this website constitutes acceptance of our user agreement. Please read our privacy policy and legal disclaimer. Opinions expressed at FXstreet.com are those of the individual authors and do not necessarily represent the opinion of FXstreet.com or its management. Risk Disclosure: Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest in foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts.
Recommended Content
Editors’ Picks
Ripple stablecoin unlikely to invite legal trouble from SEC, says Ripple executive
Ripple, the native token of the XRP Ledger slipped under $0.60, a key psychological support for the altcoin. The two key market movers are the Securities & Exchange Commission’s lawsuit against Ripple and the upcoming stablecoin RealUSD (RLUSD).
Binance burns over $950 million in BNB, will price cross $700?
Binance Coin price is nearly unchanged in the past month. Data from TradingView shows BNB price is $585 at the time of writing. On-chain metrics support a thesis of gains in BNB, as social dominance and volume climbs this week.
Dogecoin price sets for a rally following retest of support level
Dogecoin price faces rejection at the 50% Fibonacci retracement. On-chain data shows that DOGE's development activity is growing, suggesting a bullish move ahead. A daily candlestick close below $0.1018 would invalidate the bullish move.
Mt.Gox transfers $2.85 billion in Bitcoin, what to expect from BRC-20, cat-themed meme coins
Bitcoin worth $2.85 billion was transferred by Mt.Gox, crypto traders anticipate heightened selling pressure on BTC. Bitcoin-related assets like BRC-20 tokens and cat-themed meme coins typically rally or suffer correction in price alongside BTC.
Bitcoin: Will BTC continue its bullish momentum?
Bitcoin (BTC) price increased by 5.5% this week until Friday after breaking above a descending trendline. Currently, it is trading slightly higher by 0.23% at $64,166.